Adline Chem Lab
15.79
0.00(0.00%)
Market Cap₹9.20 Cr
PE Ratio-49.34
IndustryHealthcare
Company Performance:
1D0.00%
1M+25.32%
6M+46.88%
1Y0.00%
5Y+102.96%
View Company Insightsright
More news about Adline Chem Lab
14Aug 26
Adline Chem Lab Q1 Results: Net profit turns positive to ₹4.01 lakh
Adline Chem Lab Ltd returned to profit in Q1FY27 with a net income of ₹4.01 lakh, reversing a prior-year loss. Revenue reached ₹11.99 lakh against nil in Q1FY26. However, the company faced a ₹1.06 lakh BSE penalty for non-appointment of a Company Secretary, highlighting ongoing governance challenges amidst improved operational metrics.
 no imag found
12Jun 26
Adline Chem Lab accepts resignations of two independent directors
Adline Chem Lab Ltd accepted the resignations of Independent Directors Mr. Him Vyas and Mr. Krish Patel, effective June 12, 2026, due to personal and professional commitments. The company confirmed there are no other material reasons for the resignations.
 no imag found
11Feb 26
Adline Chem Lab Reports Q3FY26 Loss of ₹6.46 Lakhs, Appoints New Chairman & MD
Adline Chem Lab Limited announced Q3FY26 financial results showing a net loss of ₹6.46 lakhs, improved from ₹12.26 lakhs loss in Q3FY25, with zero revenue from operations. The company also appointed Mr. Vrushank Balkrushna Patel as Chairman and Managing Director for five years, subject to shareholder approval.
 no imag found
30Dec 25
Adline Chem Lab Updates CFO Resignation Details Following Board Changes
Adline Chem Lab Limited has submitted supplementary information regarding CFO Kuldip Ashokkumar Parekh's resignation due to better career opportunities, effective June 13, 2025. This follows the company's recent board restructuring in November 2025, where Vrushank Patel was appointed as Chairman replacing Sarang Bharatbhai Pathak. The company reported a loss before tax of ₹13.89 lakhs for the half-year ended September 30, 2025.
 no imag found
Adline Chem Lab
15.79
0.0
(0.0%)
1 Year Returns:0.00%
Industry Peers
Sun Pharmaceutical
1,743.00
(-0.90%)
Divis Laboratories
9,087.00
(-0.63%)
Torrent Pharmaceuticals
4,558.70
(+0.00%)
Laurus Labs
2,069.00
(+0.43%)
Zydus Life Science
1,113.90
(-0.81%)
Cipla
1,324.10
(-0.08%)
Dr Reddys Laboratories
1,242.50
(+0.77%)
Aurobindo Pharma
1,621.40
(-2.73%)
Mankind Pharma
2,253.20
(-0.98%)
Lupin
1,939.20
(-1.14%)